ArticleSage open pediatrics
Procalcitonin in Cord Blood: Evaluating Reference Ranges in Healthy Newborns >32 Weeks Gestation.
Article in Sage open pediatrics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study was to determine the concentration of procalcitonin (PCT) in umbilical cord blood (UCB) in healthy newborns more than 32 weeks gestational age. A total of 82 newborns were enrolled in a cross-sectional study. UCB was collected and measured for PCT levels immediately after birth. As results, the mean gestational age and birth weight was 37.55 ± 2.33 weeks, 2891.46 ± 555.82 g, respectively. The median concentration of PCT in UCB in healthy newborns was 0.097 (IQR, 0.082-0.134) ng/ml. The concentration of PCT in UCB did not differ in gestational age, gender, method of delivery, birth weight, or risk factors for prolonged rupture of membranes and maternal fever at birth. This study establishes a reference range for PCT levels in UCB in healthy neonates more than 32 weeks gestation. This baseline data can support interpreting PCT levels and improve the early diagnosis of early-onset neonatal sepsis, and help minimize unnecessary antibiotic use in newborns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.